Les cancers métastatiques du nasopharynx : étude clinique et résultats thérapeutiques de 95 cas
Authors:
- A. KhanfirAKA. Khanfir
- M. FrikhaMFM. Frikha
- A. GhorbelAGA. Ghorbel
- H. KarrayHKH. Karray
- M.-M. DriraMDM.-M. Drira
- J. DaoudJDJ. Daoud
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 10 (8) , 545-549
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaJournal of Clinical Oncology, 2005
- A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinomaOral Oncology, 2005
- Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinomaCancer, 2005
- Nasopharyngeal carcinoma in childhood and adolescenceEuropean Journal of Cancer, 2003
- Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated typeAnnals of Oncology, 2002
- Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinomaHead & Neck, 2001
- Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal TypeJournal of Clinical Oncology, 2000
- Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngealtypeAnnals of Oncology, 1999
- Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma typeHead & Neck, 1997
- Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.Journal of Clinical Oncology, 1991